Clinical Trials Browser

OTHER × Neuroendocrine Tumors × ibrutinib × Clear all

NCT02575300 2020-09-11

Phase II Study of Ibrutinib in Advanced Carcinoid and Pancreatic Neuroendocrine Tumors

Phase 2 Completed

20 enrolled 11 charts

Carcinoid Tumor, Adenoma, Islet Cell, Neuroendocrine Tumors